These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4560535)

  • 41. Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused by Candida albicans.
    Ralph ED; Barber KR; Grant CW
    Am J Nephrol; 1991; 11(2):118-22. PubMed ID: 1951471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient.
    Salemis NS; Tsolakis K; Aloizos S; Tsohataridis E
    Int J Infect Dis; 2008 Nov; 12(6):e155-7. PubMed ID: 18674943
    [No Abstract]   [Full Text] [Related]  

  • 43. Frequency of Candida albicans in Patients with Funguria.
    Jamil S; Jamil N; Saad U; Hafiz S; Siddiqui S
    J Coll Physicians Surg Pak; 2016 Feb; 26(2):113-6. PubMed ID: 26876397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical efficacy of flucytosine on urinary candidiasis].
    Yasumoto R; Asakawa M; Umeda M; Tanaka S; Tsurusaki K; Mori K; Kakinoki K; Kawashima H
    Hinyokika Kiyo; 1988 Sep; 34(9):1679-82. PubMed ID: 3213801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluconazole therapy for Candida albicans urinary tract infections in infants.
    Triolo V; Gari-Toussaint M; Casagrande F; Garraffo R; Dageville C; Boutté P; Bérard E
    Pediatr Nephrol; 2002 Jul; 17(7):550-3. PubMed ID: 12172774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.
    Grau S; Luque S; Echeverría-Esnal D; Sorlí L; Campillo N; Montero M; Álvarez Lerma F; Plasencia V; Horcajada JP
    Int J Antimicrob Agents; 2016 Aug; 48(2):212-4. PubMed ID: 27424599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Letter: Treatment of vulval candidiasis with 5-fluorocytosine.
    Seligman SA
    Br Med J; 1974 Jul; 3(5924):173-4. PubMed ID: 4602938
    [No Abstract]   [Full Text] [Related]  

  • 49. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A study on urinary fungal infection].
    Takeuchi H; Arai Y; Konami T; Ikeda T; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1983 Oct; 29(10):1273-7. PubMed ID: 6100418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.
    Steer PL; Marks MI; Klite PD; Eickhoff TC
    Ann Intern Med; 1972 Jan; 76(1):15-22. PubMed ID: 5063168
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal fungus ball in a patient with retroperitoneal fibrosis: Unique complication in a rare disease.
    Alobaid K; Faty M; El-Nahas A; Al-Terki A; Khan Z
    Mycoses; 2018 Jun; 61(6):410-416. PubMed ID: 29430718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of generalized candidiasis with 5-fluorocytosine].
    Alonso H; Aletti R; Gentiletti A
    Medicina (B Aires); 1972; 32(1):51-2. PubMed ID: 5019637
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical efficacy of fluconazole in urinary tract fungal infections].
    Nito H
    Jpn J Antibiot; 1989 Jan; 42(1):171-8. PubMed ID: 2540364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of disseminated candidiasis with 5-fluorocytosine.
    Eilard T; Alestig K; Wahlén P
    J Infect Dis; 1974 Aug; 130(2):155-9. PubMed ID: 4842336
    [No Abstract]   [Full Text] [Related]  

  • 56. Endogenous Candida oculomycosis. Report of two patients treated with flucytosine.
    Robertson DM; Riley FC; Hermans PE
    Arch Ophthalmol; 1974 Jan; 91(1):33-8. PubMed ID: 4587195
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy.
    Hoeprich PD; Ingraham JL; Kleker E; Winship MJ
    J Infect Dis; 1974 Aug; 130(2):112-8. PubMed ID: 4842332
    [No Abstract]   [Full Text] [Related]  

  • 58. Micafungin treatment and eradication of candiduria among hospitalized patients.
    Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
    Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flucytosine in the management of genitourinary candidiasis: 5 years of experience.
    Wise GJ; Kozinn PJ; Goldberg P
    J Urol; 1980 Jul; 124(1):70-2. PubMed ID: 7411725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonsurgical management of neonatal obstructive uropathy due to Candida albicans.
    McDonnell M; Lam AH; Isaacs D
    Clin Infect Dis; 1995 Nov; 21(5):1349-50. PubMed ID: 8589183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.